Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BPL-003 in Alcohol Use Disorder
NCT05674929Phase 2Completed
- Sponsor
- Beckley Psytech
- Start
- May 2023
- Primary completion
- Oct 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mebufotenin in alcohol use disorder (AUD), sponsored by Beckley Psytech. Started May 2023; status: completed.
02
Drugs
mebufotenin
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05674929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05674929.